The new executive team faces much the same issues that the two previous CEOs encountered. The portfolio of businesses that form Smiths Group have little industrial synergy which, given its historical active transitions, raises questions over whether the current structure optimises value for shareholders. Further improving operational performance appears key to facilitating strategic decisions, aided by reduced pension cash funding.


Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Patient revival
- Published:
17 Mar 2016 -
Author:
Andy Chambers -
Pages:
2 -
The new executive team faces much the same issues that the two previous CEOs encountered. The portfolio of businesses that form Smiths Group have little industrial synergy which, given its historical active transitions, raises questions over whether the current structure optimises value for shareholders. Further improving operational performance appears key to facilitating strategic decisions, aided by reduced pension cash funding.